The dangers of taking off-brand Ozempic for weight reduction, in response to a physician – CBS Information
Watch CBS News
The FDA issued a new warning about some of the popular diabetes drugs being used for weight loss after the agency “received adverse event reports after patients used compounded semaglutide.” That’s the generic name for medications like Ozempic and Wegovy. New York endocrinologist Dr. Florence Comite joins CBS News to discuss the risks of taking off-brand versions.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.